Tag: Immune checkpoint inhibitors in cancer therapy

In recent years, the intricate relationship between tumor biology and immune response has garnered significant attention, especially in the realm ...

In a groundbreaking study that could redefine treatment strategies for gastric and gastroesophageal junction (G/GEJ) cancers, researchers have unveiled critical ...

In a groundbreaking pilot study published in BMC Cancer, researchers have explored a novel “watch-and-wait” strategy for managing locally recurrent ...

A groundbreaking advancement in the treatment of advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, has emerged ...

In the evolving landscape of metastatic gastric cancer (MGC) treatment, the role of immunotherapy beyond initial progression has remained a ...

Nearly Four Decades After Its Discovery, a Well-Known Protein Emerges as a Key Player in Cancer Immune Evasion For nearly ...